| Literature DB >> 24914927 |
Norman R Saunders1, Natassya M Noor1, Katarzyna M Dziegielewska1, Benjamin J Wheaton1, Shane A Liddelow2, David L Steer3, C Joakim Ek4, Mark D Habgood1, Matthew J Wakefield5, Helen Lindsay6, Jessie Truettner7, Robert D Miller8, A Ian Smith3, W Dalton Dietrich7.
Abstract
This study describes a combined transcriptome and proteome analysis of Monodelphis domestica response to spinal cord injury at two different postnatal ages. Previously we showed that complete transection at postnatal day 7 (P7) is followed by profuse axon growth across the lesion with near-normal locomotion and swimming when adult. In contrast, at P28 there is no axon growth across the lesion, the animals exhibit weight-bearing locomotion, but cannot use hind limbs when swimming. Here we examined changes in gene and protein expression in the segment of spinal cord rostral to the lesion at 24 h after transection at P7 and at P28. Following injury at P7 only forty genes changed (all increased expression); most were immune/inflammatory genes. Following injury at P28 many more genes changed their expression and the magnitude of change for some genes was strikingly greater. Again many were associated with the immune/inflammation response. In functional groups known to be inhibitory to regeneration in adult cords the expression changes were generally muted, in some cases opposite to that required to account for neurite inhibition. For example myelin basic protein expression was reduced following injury at P28 both at the gene and protein levels. Only four genes from families with extracellular matrix functions thought to influence neurite outgrowth in adult injured cords showed substantial changes in expression following injury at P28: Olfactomedin 4 (Olfm4, 480 fold compared to controls), matrix metallopeptidase (Mmp1, 104 fold), papilin (Papln, 152 fold) and integrin α4 (Itga4, 57 fold). These data provide a resource for investigation of a priori hypotheses in future studies of mechanisms of spinal cord regeneration in immature animals compared to lack of regeneration at more mature stages.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24914927 PMCID: PMC4051688 DOI: 10.1371/journal.pone.0099080
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Number, tissue weight and protein concentration of spinal cord tissue used for proteomic analysis in this study.
| Age group | Number of cords | Tissue weight (mg) | Total protein concentration (µg/µl) |
|
| 11 | 37.7 | 4.7 |
|
| 11 | 27.8 | 5.14 |
|
| 4 | 66.5 | 6.97 |
|
| 4 | 87 | 8.74 |
Samples rostral to the site of injury (T10) were used in proteomic analysis for control and transected spinal cords of Monodelphis domestica at P7 or P28. Note that individual cords were pooled from more than one litter.
Figure 1Monodelphis domestica spinal cords injured at P7 or P28.
Longitudinal sections (hematoxylin & eosin staining) of spinal cords injured at P7 or P28 shown immediately after complete spinal transection at T10 (A, B) or 24 hours later (C, D). Note obvious bleeding into the injury site at P28 (B), which was more pronounced than at P7 (A) One day after transection (+24 h) the gap between severed ends of the cord was larger in P28 injured animals (D) than in P7 injured animals (C). Rostral end is to the left, caudal to the right, dorsal is uppermost. Scale bar is 500 µm.
Figure 2Changes in gene expression in spinal cord 24Monodelphis domestica.
Numbers of genes in each functional category that showed ±≥2 fold change compared to uninjured aged matched controls. Note dominance of immune/inflammatory genes particularly at P7. Also note that at P28 many more genes showed expression changes (both up and down). See Tables S1 and S2 for gene descriptions, fold change and p values.
Change in expression of neurite inhibitory and axon growth/guidance genes 24 h following spinal cord injury at P28.
| SYMBOL | GENE DESCRIPTION | FOLD |
|
| ||
|
| ephrin-A4 | 5.0 |
|
| Rho GTPase activating protein 6 | 3.1 |
|
| GEM interacting protein encodes a member of the ARHGAP family of Rho/Rac/Cdc42-like GTPase activating proteins. | 3.0 |
|
| similar to SMPD3 sphingomyelin phosphodiesterase | 2.4 |
|
| similar to OPHN1 oligophrenin 1,encodes Rho-GTPase-activating protein | 2.3 |
|
| myelin protein zero | 1.8 |
|
| Nogo, myelin inhibitory factor | 1.2 |
|
| myelin oligodendrocyte glycoprotein | −1.7 |
|
| myelin associated glycoprotein | −1.8 |
|
| Rho guanine nucleotide exchange factor (GEF) 10 | −2.0 |
|
| Rho GTPase activating protein 35 | −2.1 |
|
| myelin basic protein | −2.2 |
|
| proteolipid protein 1 | −2.4 |
|
| ||
|
| HHIP-like 2, hedgehog interacting protein-like 2 | 6.5 |
|
| small G protein signaling modulator 3 | 4.5 |
|
| slit homolog 3 (Drosophila) interacts with Robo; axon repellent | 4.0 |
|
| similar to DNAH7 dynein, axonemal, heavy chain | 3.1 |
|
| roundabout, axon guidance receptor, homolog 3 (Drosophila) | 3.0 |
|
| microtubule assoc monoxygenase, calponin & LIM domain containing 1 | 2.3 |
|
| serpin peptidase inhib, clade F α-2 antiplasmin, pigment epithelium factor) | 2.3 |
|
| transforming growth factor, β 3, regulator of ECMs and integrins | 2.2 |
|
| netrin 5 | 2.1 |
|
| transcription elongation regulator 1-like | 2.0 |
|
| engulfment and cell motility 3 | 2.0 |
|
| contactin 2 (axonal) [Source:HGNC Symbol;Acc:2172] | −2.0 |
|
| sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) | −2.0 |
|
| astrotactin 1, neuronal adhesion molecule required for glial-guided migration of young postmitotic neuroblasts, previously described in developing brain | −2.1 |
|
| oligodendrocyte lineage transcrip factor 2, enhances myelination after SCI | −2.1 |
|
| p21 protein (Cdc42/Rac)-activated kinase 7 | −2.3 |
|
| pleckstrin homology domain containing, family B (evectins) member 1 | −2.4 |
|
| sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain TMand short cytoplasmic domain, (semaphorin) 5A | −2.4 |
|
| sema domain, immunoglobulin domain (Ig), short basic domain, secreted | −2.5 |
|
| p21 protein (Cdc42/Rac)-activated kinase 2 | −2.9 |
|
| growth arrest-specific 7, neurite outgrowth in some cultured neurons | −7.7 |
Change in expression of neurite inhibitory and axon growth/guidance genes in rostral spinal cord 24 h following spinal cord injury at P28. Note that most of the myelin inhibitory factor genes have not changed their expression in response to injury (fold <2).
Change in expression of channel, synapse, neural receptor, actin, myosin and related genes 24
| SYMBOL | GENE DESCRIPTION | FOLD |
|
| ||
|
| G protein-coupled receptor 26 | 6.6 |
|
| transient receptor potential cation channel, subfamily C, member 7 | 4.6 |
|
| hypocretin (orexin) neuropeptide precursor | 3.8 |
|
| Similar to UNC80 unc-80 homolog (C. elegans) | 3.7 |
|
| synaptotagmin-like 1 | 3.0 |
|
| FCH and double SH3 domains 1 | 3.0 |
|
| adenosine A2a receptor | 3.0 |
|
| family with sequence similarity 40, member B, correct symbol STRIP2 | 3.0 |
|
| chloride channel, voltage-sensitive 2 | 2.6 |
|
| benzodiazapine receptor (peripheral) associated protein 1 | 2.6 |
|
| microtubule associated serine/threonine kinase 1 | 2.4 |
|
| tRNA phosphotransferase 1 | 2.4 |
|
| syntaxin binding protein 2 | 2.3 |
|
| mucolipin 1 | 2.3 |
|
| chromosome 10 open reading frame 10 | 2.3 |
|
| anoctamin 8 | 2.1 |
|
| calcium channel, voltage-dependent, beta 3 subunit | 2.1 |
|
| adrenergic, beta, receptor kinase 2 | 2.0 |
|
| calcium/calmodulin-dependent protein kinase 1α, modulation of neuron survival | 2.0 |
|
| synaptotagmin II | −1.8 |
|
| transient receptor potential cation channel, subfamily C, member 4 assoc prot | −2.1 |
|
| G protein-coupled receptor, family C, group 5, member B | −2.1 |
|
| neuronal calcium sensor 1 | −2.1 |
|
| kinesin family member 1B | −2.2 |
|
| GRB2-associated binding protein 1 | −2.2 |
|
| potassium inwardly-rectifying channel, subfamily J, member 10 | −2.3 |
|
| shroom family member 2 | −2.5 |
|
| synapsin III | −2.5 |
|
| G protein-coupled receptor 17 | −2.6 |
|
| gamma-aminobutyric acid (GABA) A receptor, beta 1 | −2.9 |
|
| probable G-protein coupled receptor 75 | −2.9 |
|
| potassium inwardly-rectifying channel, subfamily J, member 12 | −5.8 |
|
| similar to CLCNKA/CLCNKB chloride channel | −27 |
|
| ||
|
| triadin | 206 |
|
| myosin, light chain 1, alkali; skeletal, fast | 139 |
|
| myosin light chain, phosphorylatable, fast skeletal muscle | 22 |
|
| myosin, heavy chain 4, skeletal muscle | 18 |
|
| actin, alpha 1, skeletal muscle | 8.6 |
|
| myosin binding protein C, cardiac | 4.8 |
|
| parvin, gamma | 4.7 |
|
| LOC100015891 Similar to Myosin heavy chain | 4.6 |
|
| phosphoglycerate mutase 2 (muscle) | 4.3 |
|
| myoferlin | 4.2 |
|
| nexilin (F actin binding protein) | 4.0 |
|
| myosin XIX | 3.7 |
|
| tropomyosin 2 (beta) member of the actin filament binding protein family | 3.1 |
|
| myo-inositol oxygenase | 2.9 |
|
| SPEG complex locus | 2.8 |
|
| similar to actinin alpha, F-actin cross-linking protein | 2.8 |
|
| transgelin 22 kDa actin-binding protein | 2.7 |
|
| ryanodine receptor 3 brain ryanodine receptor-calcium release channel | 2.7 |
|
| tubulin tyrosine ligase-like family, member 9 | 2.6 |
|
| nebulin | 2.6 |
|
| myosin IF | 2.6 |
|
| LOC100014836 similar to ACTA1 actin, alpha 1, skeletal muscle | 2.2 |
|
| popeye domain containing 3 | −2.2 |
|
| kinesin family member 13B | −2.3 |
Change in expression of channel, synapse, neural receptor, actin, myosin and related genes 24 h following spinal cord injury at P28. Note that myosin and actin genes are important structural and functional components of synapses.
Figure 3Changes in gene expression 24
Only 40 genes changed their expression levels by ≥2 fold. All were upregulated. See Table S1 for gene descriptions and statistics. There were 12 “novel” genes; search of GO categories showed that these have immune/inflammatory properties. Note that only four of the genes in this figure (green bars) are not in the immune/inflammatory category (blue bars).
Figure 4Interleukin-1β in Monodelphis spinal cord 24 hours after a complete transection at P7 or P28.
In the segment of the cord rostral to the site of injury Il-1β was detected using cross-reacting antibodies to the human cytokine. Note strong immunopositive signal in the tissue surrounding the cords at P7-injured (A) and P28 (B) but lack of significant staining within the spinal tissue especially at P7 (A). One day following injury at P28 a few immunopositive cells with the general morphology of monocytes were detected, especially in segments of the cord more rostral to the injury (C). Scale bars A, B = 500 µm, C = 100 µm.
Figure 5Comparison of expression levels of the twenty-six genes that changed expression in spinal cord 24 h following transection at both P7 and P28.
All but two of these genes (Timp1 and Stxbp2) were in the immune/inflammatory category. The magnitude of the expression changes was generally similar at the two ages, but more genes (six: IL1β, MARCO, novel-2, CSF2RB, IL1-R1, novel-4) showed greater upregulation at P7 than at P28 (three: novel-1, novel-6, novel-7). A search of Ensembl, NCBI “Gene” and GO categories showed that all of these novel genes are involved in immune/inflammatory functions (see Tables S1 and S2).
Figure 6Myelin staining in the developing spinal cord of Monodelphis domestica.
Transverse sections through thoracic spinal cord of P8 (A) and P29 (B) spinal cord stained with Luxol fast blue (LFB). There was no LFB stained myelin at P8 (A) but relatively well- developed myelin was present at P28 (B). However even at P28 the myelination is only beginning to appear (first detected between P21 and P28) and does not reach adult levels until several weeks later (not illustrated). Dorsal is uppermost. Scale bar is 500 µm.
Change in expression of extracellular matrix factor genes in 24
| SYMBOL | GENE DESCRIPTION | FOLD |
|
| ||
|
| olfactomedin 4, also OlfD, hOlfD, ECM glycoprotein that facilitates cell adhesion. | 480 |
|
| matrix Gla protein | 5.1 |
|
| collagen, type XXI, alpha 1 | 4.8 |
|
| similar to AMY cluster collagen COL25A1 | 4.3 |
|
| collagen, type XXIV, alpha 1 | 3.5 |
|
| lysyl oxidase | 3.4 |
|
| extracellular matrix protein 1 | 3.2 |
|
| peroxidasin homolog (Drosophila) | 2.9 |
|
| collagen, type VII, alpha 1 | 2.9 |
|
| superoxide dismutase 3, extracellular | 2.6 |
|
| serine/arginine repetitive matrix 4 | 2.4 |
|
| fibrillin 3 | 2.3 |
|
| collagen, type XXVII, alpha 1 | 2.0 |
|
| collagen, type XV, alpha 1 | −2.0 |
|
| dystroglycan 1 (dystrophin-associated glycoprotein 1) | −2.0 |
|
| elastin microfibril interfacer 2 | −2.1 |
|
| neurofascin, L1 family immunoglobulin cell adhesion molecule with multiple IGcam and fibronectin domains: neurite outgrowth, neurite fasciculation | −2.2 |
|
| nidogen 2 (osteonidogen) binds collagens I and IV and laminin | −2.2 |
|
| ||
|
| extracellular leucine-rich repeat and fibronectin type III domain containing 2 | −2.9 |
|
| ||
|
| ADAM metallopeptidase domain 11 | 3.0 |
|
| ADAM metallopeptidase with thrombospondin type 1 motif, 10 | 2.5 |
|
| endoplasmic reticulum metallopeptidase 1 | −2.0 |
|
| ADAM metallopeptidase domain 17 | −2.1 |
|
| carnosine dipeptidase 1 (metallopeptidase M20 family) | −2.2 |
|
| ||
|
| TIMP metallopeptidase inhibitor 1 | 4.4 |
|
| ||
|
| matrix metallopeptidase 1 (interstitial collagenase) | 104 |
|
| matrix metallopeptidase 15 (membrane-inserted) | −2.4 |
|
| ||
|
| papilin, proteoglycan-like sulfated glycoprotein | 152 |
|
| brevican | 2.1 |
|
| similar to HS2ST1 heparan sulfate 2-O-sulfotransferase 1 | −2.6 |
|
| exostoses (multiple)-like 1 | −3.0 |
|
| ||
|
| lamin gamma 3 | 4.8 |
|
| lamini beta 2 | 2.6 |
|
| laminin gamma 2 | 2.4 |
|
| laminin gamma 1 | 2.2 |
|
| laminin alpha 4 | 2.0 |
|
| ||
|
| integrin beta 1 binding protein (melusin) 2 | 6.2 |
|
| integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 6.1 |
|
| integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | −57 |
Change in expression of extracellular matrix (ECM) factor genes 24 h following spinal cord injury at P28, subdivided into ECM, metallopeptidases, inhibitors, proteoglycans, laminins and integrins.
Figure 7Proteins by functional groups with changed expression levels after spinal transection at P7 or P28.
Estimates of protein expression levels from densitometry measurements. Values are expressed as % change from control values (100%). y axis: Relative Density (%). Proteins grouped by functions as listed in Tables S4 and S5. Abbreviations: TPPP3-Brain specific protein; UQCRC2-Ubiquinol-cytochrome c reductase core protein II; EEF2-Elongation factor 2 isoform 1; LGALS1-galactin1; MBP–Myelin basic protein; PRDX1-peroxiredoxin1; PRDX2–peroxiredoxin 2; PRDX6–peroxiredoxin 6; PSMB1-Proteasome subunit β type 1; UBC–Ubiquitin C; UBA52-Ubiquitin A-52; USP30-Ubiquitin specific peptidase 30 phosphoglycerate kinase; BC12-NEDD8-conjugating enzyme UBC12; DYNLL1- Cytoplasmic dynein light chain 1; DYNLL2-Dynein light chain LC8 type 2; VSLN1-Visinin like-1; AC39-AC39/physophilin; GFAP–glial fibrillary acidic protein; TAGLN2-transgelin 2; PPIAL4A - Peptidylprolyl isomerase A-like PEBP1 - Phosphatidylethanolamine-binding protein 1; PARK7 - Parkinson protein 7; Neurofil-L – Neurofilament-L subunit; PPP2R2B - Protein phosphatase 2 regulatory subunit B. Two proteins, VSNL1 and PPIAL4A (marked with *) are mean values as their expression levels changes were detected in more than one fraction (see Table S4 and S5 for individual changes). Note also that a few of the proteins listed showed both up- and downregulation but only in P28 injury group.
Figure 8Summary of numbers of proteins that changed expression levels 24
All but five of the proteins identified at P7 as showing a change in expression after injury were downregulated. At P28 half of the proteins were upregulated.
Genes that changed most in expression (±≥10 FOLD) 24 h following spinal cord injury at P28.
| SYMBOL | GENE DESCRIPTION | FOLD | ||
|
| ||||
|
| ||||
|
| C-C motif chemokine similar to CCL8 and CCL13 | 322 | ||
|
| docking protein 3 | 266 | ||
|
| C-C motif chemokine similar to CCL2, CCL7, CCL8, CCL11 and CCL13 | 197 | ||
|
| proline-serine-threonine phosphatase interacting protein 1 | 167 | ||
|
| leucine rich repeat containing 33 Official name NRROS | 160 | ||
|
| similar to TARM1 T cell-interacting, activating receptor on myeloid cells 1 | 22 | ||
|
| interleukin 1, β | 20 | ||
|
| VAV1 guanine nucleotide exchange factor | 17 | ||
|
| oncostatin M receptor | 14 | ||
|
| lectin, galactoside-binding, soluble, 4 | 14 | ||
|
| anti-Mullerian hormone | 12 | ||
|
| macrophage receptor with collagenous structure | 12 | ||
|
| immunoglobulin superfamily, member 22 | 12 | ||
|
| LOC100020928 C-C motif chemokine similar to CCL3 and CCL4 | 10 | ||
|
| ||||
|
| similar to HPR, haptoglobin-related protein | 99 | ||
|
| similar to TARM1 T cell-interacting, activating receptor on myeloid cells 1 | 22 | ||
|
| ||||
|
| olfactomedin 4, ECM glycoprotein that facilitates cell adhesion. | 480 | ||
|
| ||||
|
| matrix metallopeptidase 1 (interstitial collagenase) | 104 | ||
|
| ||||
|
| papilin, proteoglycan-like sulfated glycoprotein | 152 | ||
|
| ||||
|
| triadin | 206 | ||
|
| myosin, light chain 1, alkali; skeletal, fast | 139 | ||
|
| myosin light chain, phosphorylatable, fast skeletal muscle | 22 | ||
|
| myosin, heavy chain 4, skeletal muscle | 18 | ||
|
| ||||
|
| solute carrier family 23, sodium-dependent vitamin C transporter 3 | 12 | ||
|
| ||||
|
| fuzzy homolog (Drosophila) cell polarity, ciliogenesis & cell movement. | 21 | ||
|
| homeobox B1, transcription factor role in morphogenesis | 12 | ||
|
| desmin | 12 | ||
|
| ||||
|
| novel protein with potential transmembrane domains | 254 | ||
|
| novel protein with potential transmembrane domains | 241 | ||
|
| transmembrane protein 106A | 157 | ||
|
| ||||
|
| proline-serine-threonine phosphatase interacting protein 1 | 167 | ||
|
| similar to ATP13A5 ATPase type 13A5 | 23 | ||
|
| ||||
|
| tetratricopeptide repeat domain 40 | 89 | ||
|
| ||||
|
| similar to ZC3H13 zinc finger CCCH-type containing 13 | 352 | ||
|
| ||||
|
| integrin, α 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | −57 | ||
|
| similar to CLCNKA/CLCNKB chloride channel | −27 | ||
|
| insulin-like growth factor binding protein-like 1 | −11 | ||
|
| glucoside xylosyltransferase 2 | −16 | ||
Proteins that changed level 24Monodelphis in segments rostral and caudal to site of transection.
| Protein | Rostral SC | Caudal SC |
| 14-3-3 |
|
|
| cofilin |
|
|
| destrin |
|
|
| Hemoglobin α |
|
|
| Hemoglobin subunit β M |
|
|
| Peptidylprolyl isomerase a-like |
|
|
| Pyruvate dehydrogenase |
|
|
| Tubulin α |
|
|
| Tubulin β |
|
|
| ubiquitin |
|
|
increased band density, decreased band density. Some proteins showed an increase or decrease in different fractions ( ).
Proteins that changed level 24Monodelphis in segments rostral and caudal to site of transection.
| Protein | Rostral SC | Caudal SC |
| 14-3-3 protein |
|
|
| albumin |
|
|
| Alpha enolase | □ |
|
| Annexin-a2 |
|
|
| ATP synthase subunit β, mitochondrial |
|
|
| cofilin |
|
|
| GFAP |
|
|
| Glyceraldehyde 3 phosphate dehydrogenase |
|
|
| Hemoglobin subunit β M |
|
|
| Neurofilament L subunit |
|
|
| Peptidylprolyl isomerase A-like |
|
|
| Tropomyosin |
|
|
| Tubulin α |
|
|
| ubiquitin |
|
|
increased band density, decreased band density. Some proteins showed an increase or decrease in different fractions ( ).